The Gen XY Lifestyle

Breathe Easier: Next-Gen AirSense™ 11 CPAP by ResMed Lands in Singapore

By  |  0 Comments

Sleep apnoea is a serious condition where breathing repeatedly stops and starts during sleep, leading to poor sleep quality and other health issues.

It affects millions worldwide, causing daytime fatigue, cardiovascular problems, and impaired cognitive function.

ResMed has launched its next-gen CPAP device, the AirSense™ 11, in Singapore. Designed to simplify sleep apnoea therapy with advanced digital tools, this device is set to revolutionise how patients manage their condition.

ResMed

Key Features:

  • Personal Therapy Assistant: Step-by-step setup via the myAir app for easy acclimation.
  • Care Check-In: Personalised feedback and guidance through the myAir app and device screen.
  • Test Drive: Try different pressure levels for comfortable therapy.
  • Sleek Design: Intuitive touchscreen interface.
  • Smart Algorithms: Auto-adjusting PAP therapy, including a mode for women.
  • Over-the-Air Upgrades: Ensure the latest features and improved therapy outcomes.

Impact and Accessibility

Manufactured in Singapore, the AirSense™ 11 is a testament to ResMed’s commitment to digital health. It offers tools that improve therapy adherence, with myAir and AirView platforms providing comprehensive support and monitoring.

Available through authorised distributors, the AirSense™ 11 aims to enhance sleep quality and overall well-being in Singapore.

For more info or to assess your sleep health, check out ResMed’s Sleep Assessment Tool.


Pictures attributed to ResMed.

Comments

comments